2020

主な論文・総説・著書

1. Effect of lipid shell composition in DSPG-based microbubbles on blood flow imaging with ultrasonography  Tamotsu Maruyama, Mutsumi Sugii, Daiki Omata, Johan Unga, Tadamitsu Shima, Lisa Munakata, Saori Kageyama, Fumiko Hagiwara, Yuno Suzuki, Kazuo Maruyama, Ryo Suzuki, Int. J. Pharm., 590, 119886, 2020,   DOI:10.1016/j.ijpharm.2020.119886
2. A pilot study on efficacy of lipid bubbles for theranostics in dogs with tumors.　 Inoru Yokoe, Yusuke Murahata, Kazuki Harada, Yuji Sunden, Daiki Omata, Johan Unga, Ryo Suzuki, Kazuo Maruyama, Yoshiharu Okamoto, Tomohiro Osaki.  Cancers, 12(9), 2423-2443, 2020. DOI:10.3390/cancers12092423
3. Characterization of Brain-targeted Drug Delivery Enhanced by a Combination of Lipid-based Microbubbles and Non-focused Ultrasound. Daiki Omata, Fumiko Hagiwara, Lisa Munakata, Tadamitsu Shima, Saori Kageyama, Yuno Suzuki, Takashi Azuma, Shu Takagi, Kazuhiko Seki, Kazuo Maruyama, Ryo Suzuki. J. Pharm. Sci. 109, 2827-2835, 2020   DOI:10.1016/j.xphs.2020.06.008
4. The application of the in-situ hyperthermia emission from acoustic nanodroplets for theranostic dual-imaging and antitumor modalities. Rodi Abdalkader, Johan Unga, Kazuo Maruyama, Fumiyoshi Yamashita, Mitsuru Hashida. Biol Pharm Bull, 43(7),1141-1145, 2020  doi: 10.1248/bpb.b20-00171
5. Scale-up production, characterization and toxicity of a freeze-dried lipid-stabilized microbubble formulation for ultrasound imaging and therapy.  Johan Unga, Saori Kageyama, Ryo Suzuki, Daiki Omata, Kazuo Maruyama.  J. Liposome Res. 30(3), 297-304, 2020
6. Lipid-based Microbubbles and Ultrasound forTherapeutic Application.　Daiki Omata, Johan Unga, Ryo Suzuki, Kazuo Maruyama. Advanced Drug Delivery Rev.,154-155, 236-244, 2020  DOI: 10.1016/j.addr.2020.07.005
7. 最近の超音波による癌治療　ーその可能性と課題ー　New development of ultrasonic cancer therapy  - The possibility and some of the difficulties -  近藤隆、鈴木亮、佐々木東、滝口満喜　Thermal Med., 36(3), 75-90, 2020
8. 最終講義　バブル＋超音波によるドラッグデリバリーシステム、Bubble-Ultrasound mediated Drug Delivery System (BUS-DDS)　丸山一雄　ファルマシア　56（6）556−557，2020